Log In
BCIQ
Print this Print this
 

AFM12

  Manage Alerts
Collapse Summary General Information
Company Affimed N.V.
DescriptionTetravalent bispecific human antibody that retargets natural killer (NK) cells to tumor cells
Molecular Target CD19 ; Fc gamma receptor IIIa (FCGR3A) (FcgammaRIIIa) (CD16a)
Mechanism of ActionBispecific antibody
Therapeutic ModalityBiologic: Antibody

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today